×
More Charts Below
SOPHiA GENETICS SA Total Liabilities 2020-2024 | SOPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
SOPHiA GENETICS SA total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Quarterly Chart
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$35.1B
Tempus AI (TEM)
$7B
Hims & Hers Health (HIMS)
$6B
Inspire Medical Systems (INSP)
$4.5B
IRhythm Technologies (IRTC)
$3.2B
Privia Health (PRVA)
$2.9B
Schrodinger (SDGR)
$1.9B
Clover Health Investments (CLOV)
$1.8B
Enovis (ENOV)
$1.8B
Omnicell (OMCL)
$1.4B
Phreesia (PHR)
$1.4B
Azenta (AZTA)
$1.2B
10x Genomics (TXG)
$918M
Butterfly Network (BFLY)
$568M
Fulgent Genetics (FLGT)
$551M
Talkspace (TALK)
$450M
Veradigm (MDRX)
$449M
Standard BioTools (LAB)
$440M
TruBridge (TBRG)
$363M
Claritev (CTEV)
$325M
Health Catalyst (HCAT)
$270M
Nyxoah SA (NYXH)
$206M
Pulmonx (LUNG)
$182M
American Well (AMWL)
$109M
EUDA Health Holdings (EUDA)
$100M
Retrieve Medical Holdings (RMHI)
$82M
MDxHealth SA (MDXH)
$76M
P3 Health Partners (PIII)
$66M
111 (YI)
$64M
CareCloud (CCLD)
$60M